Mergers and acquisitions – Page 16
-
Business
AstraZeneca shells out $4.1bn for diabetes business
Bristol-Myers Squibb exits the diabetes field with plans to become a specialised biopharmaceutical company
-
Business
Merck KGaA snaps up electronic materials specialist
Firm looks to bolster R&D by acquiring AZ Electronic Materials
-
Business
Pfizer teams up with GSK in cancer drug trial
Two companies will collaborate to develop a combination therapy for melanoma
-
Business
DSM to spin out pharma unit
Firm will combine with Patheon to provide manufacturing services
-
Business
Rapid DNA sequencing cleared for the clinic
Illumina’s ‘next-generation’ MiSeqDx platform gets US approval
-
Business
Novartis sells off blood diagnostics division
$1.7bn deal reinforces firm’s focus on core pharmaceuticals
-
Business
Shire will cut UK R&D to focus on rare diseases
$4.2bn buyout of ViroPharma bolsters pipeline, while Basingstoke site halts research
-
Business
Solvay expands surfactants business with Chemlogics buyout
$1.3bn deal brings firm into booming US oil and gas drilling market
-
Business
Aspen acquires anticoagulant brands
South African drugmaker buys thrombosis drugs from GSK for £700m
-
Business
Clariant expands into China
Firm buys pigments arm of Jiangsu Multicolor and will build new plant
-
Business
Algal oil producer steps up supply
Solazyme to provide 10,000 tonnes of tailored oil to Unilever
-
Business
Nanobody inflammation drug attracts Abbvie
$840m licensing deal shows support for antibody fragments
-
Business
GSK divests Lucozade and Ribena brands
£1.35 billion deal allows GSK to focus on pharma business
-
Business
Otsuka to buy Astex for $886 million
Japanese firm intends to leave Astex’s fragment-based R&D efforts intact
-
Business
Amgen snaps up Onyx in huge biotech deal
$10.4 billion acquisition will expand firm’s oncology portfolio
-
Business
Endo Health to buy Boca Pharmacal for $225m
Endo agrees to buy generics firm Boca as two major patents expire
-
Business
J&J buys Aragon’s prostate cancer arm
Hormone cancer specialist spins out other programmes before sale
-
Business
AkzoNobel sells building adhesives unit for €260m
Sika will take on two manufacturing sites and 550 employees